access

News

Many patients still denied cancer drugs in UK, survey finds

The Institute for Cancer Research has called for action to improve access to innovative cancer treatments after a new survey found that many UK patients are being denied drugs and see the p

Views & Analysis

Cost concerns with the new NHS pricing scheme

A new pricing scheme, which took effect this month, has raised the cap on NHS spending on branded drugs slightly.

White Papers

Thinking niche: the challenge of pharma's focus on small pat...

With the pharma industry putting the ‘blockbuster’ age behind it and moving into meeting needs across myriad niche disease areas, what is the impact and therefore change of requirement in terms of

Partner Content

Partner Content

Industry experts set to transform evolving pre-approval & un...

Created in response to unprecedented global demand from patients and physicians and to provide a long-sought after alternative for the biopharma

Views & Analysis

A healthy discussion on funding tomorrow’s treatments

The adage 'do more with less' is of increasing relevance to global economies, with governments under pressure to cut and compress public spend yet simultaneously increase both productivity and

Partner Content

Partner Content

The new CDF - Navigating Cancer Drug Access in England

On July 29th 2016, the new process in England for cancer drugs seeking license went live - changing both the shape and potential requirements of the submissions process.

Many patients still denied cancer drugs in UK, survey finds

Cost concerns with the new NHS pricing scheme

Thinking niche: the challenge of pharma's focus on small pat...

Industry experts set to transform evolving pre-approval & un...

A healthy discussion on funding tomorrow’s treatments

The new CDF - Navigating Cancer Drug Access in England

Alzheimer's biotech Korsana to go public via reverse merger

Using AI-driven synthetic personas to take your insights fur...

access

Editor's Picks